Intangible Asset

6 Months Ended

Jun. 30, 2026

Intangible Asset [Abstract]

INTANGIBLE ASSET

NOTE 5:- INTANGIBLE ASSET

The table below summarizes the activity in the intangible asset during the periods included in these consolidated financial statements:

		Brand				IP Portfolio*				Excess Purchase Price**				Total
Cost:
Balance as of January 1, 2026		$	4,861			$	-			$	-			$	4,861
Additions			-				1,028				10,320				11,348

Balance as of June 30, 2026			4,861				1,028				10,320				16,209

Accumulated amortization and impairment charges:
Balance as of January 1, 2026			3,691				-				-				3,691
Additions			85				-				-				85

Balance as of June 30, 2026			3,776				-				-				3,776

Net balance as of June 30, 2026			1,085				1,028				10,320				12,433
Net balance as of December 31, 2025			1,170				-				-				1,170

*	See Note 11g.
**	See Note 4.

During the six months ended June 30, 2026, and 2025, the Company recorded amortization expenses with respect to intangible asset in the amount of $85 and $96, respectively.

On October 10, 2025, the Company sold its holding in SNI to NeuroThera as part of the Transaction (see note 7h).